Transcutaneous antigen delivery system

키워드

참고문헌 (77)

1. Combadiere, B., "Transcutaneous and intradermal vaccination", Hum. Vaccine, 7, pp.811~827 (2011)
2. Glenn, G. M., "Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge", J. Immunol, 161, pp.3211~3214 (1998)
3. Huang, Y., "Synthetic skin-permeable proteins enabling needleless immunization", Angew. Chem. Int. Ed. Engl, 49, pp.2724~2727 (2010)
4. Bal, S. M., "Advances in transcutaneous vaccine delivery: do all ways lead to Rome?", J. Control Release, 148, pp.266~282 (2010)
5. Kirschner, N., "Barriers and more: functions of tight junction proteins in the skin", Ann. N. Y. Acad. Sci, 1257, pp.158~166 (2012)
6. Karande, P., "Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies", Annu. Rev. Chem. Biomol. Eng, 1, pp.175~201 (2010)
7. Clark, R. A., "Skin-resident T cells: the ups and downs of on site immunity", J. Invest. Dermatol, 130, pp.362~370 (2010)
8. Glenn, G. M., "Transcutaneous immunization: a human vaccine delivery strategy using a patch", Nat. Med, 6, pp.1403~1406 (2000)
9. Valladeau, J., "Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules", Immunity, 12, pp.71~81 (2000)
10. Ochoa, M. T., ""Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages", J. Invest. Dermatol, 128, pp.2225~2231 (2008)
11. Toebak, M. J., "Dendritic cells: biology of the skin", Contact Dermatitis, 60, pp.2~20 (2009)
12. Romani, N., "Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin", Immunol. Rev, 234, pp.120~141 (2010)
13. Zaba, L. C., "Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages", J. Clin. Invest, 117, pp.2517~2525 (2007)
14. Nestle, F. O., "Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets", J. Immunol, 151, pp.6535~6545 (1993)
15. Klechevsky, E., "Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines", Hum. Immunol, 70, pp.281~288 (2009)
16. Bedoui, S., "Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells", Nat. Immunol, 10, pp.488~495 (2009)
17. Klechevsky, E., "Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells", Immunity, 29, pp.497~510 (2008)
18. Caux, C., "CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony- stimulating factor plus tumor necrosis factor alpha: II", Functional analysis. Blood, 90, pp.1458~1470 (1997)
19. Dubois, B., "Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes", J. Immunol, 161, pp.2223~2231 (1998)
20. Sixt, M., "The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node", Immunity, 22, pp.19~29 (2005)
21. Li, N., "Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers", Vaccine, 29, pp.6179~6190 (2011)
22. Bos, J. D., "The 500 Dalton rule for the skin penetration of chemical compounds and drugs", Exp. Dermatol, 9, pp.165~169 (2000)
23. Brown, M. B., "Transdermal drug delivery systems: skin perturbation devices", Methods Mol. Biol, 437, pp.119~139 (2008)
24. Sieg, A., "Diagnostic and therapeutic applications of iontophoresis", J. Drug Target, 17, pp.690~700 (2009)
25. Batheja, P., "Transdermal iontophoresis", Expert Opin. Drug Deliv, 3, pp.127~138 (2006)
26. Charoo, N. A., "Electroporation: an avenue for transdermal drug delivery", Curr. Drug Deliv, 7, pp.125~136 (2010)
27. Chen, X., "Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology", J. Control. Release, 159, pp.43~51 (2012)
28. Vrdoljak, A., "Coated microneedle arrays for transcutaneous delivery of live virus vaccines", J. Control. Release, 159, pp.34~42 (2012)
29. Polat, B. E., "Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends", J. Control. Release, 152, pp.330~348 (2011)
30. Peachman, K. K., "Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen", Infect. Immun, 74, pp.794~797 (2006)
31. Watabe, S., "Protection against influenza virus challenge by topical application of influenza DNA vaccine", Vaccine, 19, pp.4434~4444 (2001)
32. Wang, J., "Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complex", Exp. Dermatol, 16, pp.724~729 (2007)
33. Partidos, C. D., "Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination", J. Control. Release, 85, pp.27~34 (2002)
34. Beignon, A. S., "Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus- specific CD4+ T cells", Immunology, 105, pp.204~212 (2002)
35. Naohiro, S., "Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis", Proc. Natl. Acad. Sci. U.S.A, 97, pp.371~376 (2000)
36. Hirobe, S., "Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria", Vaccine, 30, pp.1847~1854 (2012)
37. Joshi, N., "Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells", PLoS One, 7, pp.e32067~ (2012)
38. Brooks, N. A., "Cell-penetrating peptides: application in vaccine delivery", Biochim. Biophys. Acta, 1805, pp.25~34 (2010)
39. Tarique, A. A., "Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice", Clin. Vaccine Immunol, 19, pp.594~602 (2012)
40. Mawas, F., "Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine", J. Infect. Dis, 190, pp.1177~1182 (2004)
41. Slovin, S. F., "Carbohydrate vaccines as immunotherapy for cancer", Immunol. Cell Biol, 83, pp.418~428 (2005)
42. Ouerfelli, O., "Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities", Expert Rev. Vaccines, 4, pp.677~685 (2005)
43. Skountzou, I., "Transcutaneous immunization with inactivated influenza virus induces protective immune responses", Vaccine, 24, pp.6110~6119 (2006)
44. El-Ghorr, A. A., "Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice", FEMS Immunol. Med. Microbiol, 29, pp.255~261 (2000)
45. Zhang, J., "Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity", Infect. Immun, 74, pp.3607~3617 (2006)
46. Mishra, D., "Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response", Nanomedicine, 6, pp.110~118 (2010)
47. Benson, H. A., "Transfersomes for transdermal drug delivery", Expert Opin. Drug Deliv, 3, pp.727~737 (2006)
48. Cui, Z., "Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid", Int. J. Pharm, 317, pp.187~191 (2006)
49. Vyas, S. P., "Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B", Int. J. Pharm, 296, pp.80~86 (2005)
50. Boyer, C., "Multiple lipid compartments slow vesicle contents release in lipases and serum", ACS Nano, 1, pp.176~182 (2007)
51. Kim, Y. C., "Transdermal delivery enhanced by magainin pore-forming peptide", J. Control. Release, 122, pp.375~383 (2007)
52. Himes, R., "The influence of molecular adjuvants in the cutaneous response to antigen after topical vaccination", Vaccine, 29, pp.5393~5398 (2011)
53. Tomoka, T-N., "Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response", PLoS One, 7, pp.e47980~ (2012)
54. Gupta, R. K., "Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid", Biologicals, 22, pp.53~63 (1994)
55. Beignon, A. S., "Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge", Immunology, 102, pp.344~351 (2001)
56. Glenn, G. M., "Skin immunization made possible by cholera toxin", Nature, 391, pp.851~ (1998)
57. Connell, T. D., "Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins", Expert Rev. Vaccines, 6, pp.821~834 (2007)
58. Scharton-Kersten, T., "Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants", Infect. Immun, 68, pp.5306~5313 (2000)
59. Olvera-Gomez, I., "Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination", Proc. Natl. Acad. Sci. U.S.A, 109, pp.2072~2077 (2012)
60. Wilson-Welder, J. H., "Vaccine adjuvants: current challenges and future approaches", J. Pharm. Sci, 98, pp.1278~1316 (2009)
61. Riminton, D. S., "Dermal enhancement: bacterial products on intact skin induce and augment organ-specific autoimmune disease", J. Immunol, 1, pp.302~309 (2004)
62. Rechtsteiner, G., "Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod", J. Immunol, 174, pp.2476~2480 (2005)
63. Weldon, W. C., "Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine", PLoS One, 7, pp.e41501~ (2012)
64. Scott, E. A., "Dendritic cell activation and T cell priming with adjuvant- and antigenloaded oxidation-sensitive polymersomes", Biomaterials, 33, pp.6211~6219 (2012)
65. Chang, B. A., "Topical resiquimod promotes priming of CTL to parenteral antigens", Vaccine, 27, pp.5791~5799 (2009)
66. Verthelyi, D, "Differential signaling by CpG DNA in DCs and B cells: not just TLR9", Trends Immunol, 24, pp.519~522 (2003)
67. Dongbum Kim, "Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA", BMB Reports, 44(9), pp.607~612 (2011), 생화학분자생물학회
68. Dongbum Kim, "Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA", BMB Reports, 44(11), pp.758~763 (2011), 생화학분자생물학회
69. Diwan, M., "Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres", J. Control. Release, 85, pp.247~262 (2002)
70. Slütter, B., "Adjuvant effect of cationic liposomes and CpG depends on administration route", J. Control. Release, 154, pp.123~130 (2011)
71. Ozaki, T., "Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant", Viral Immunol, 18, pp.373~380 (2005)
72. Belyakov, I. M., "Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells", J. Clin. Invest, 113, pp.998~1007 (2004)
73. Inoue, J., "Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides", Vaccine, 25, pp.1007~1013 (2007)
74. Hickey, D. K., "Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection", Vaccine, 27, pp.6983~6990 (2009)
75. Hickey, D. K., "Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF", Curr. Mol. Med, 5, pp.559~605 (2005)
76. Huang, C. M., "Surfactant sodium lauryl sulfate enhances skin vaccination: molecular characterization via a novel technique using ultrafiltration capillaries and mass spectrometric proteomics", Mol. Cell. Proteomics, 5, pp.523~532 (2006)
77. Karande, P., "Transcutaneous immunization using common chemicals", J. Control. Release, 138, pp.134~140 (2009)

관련 논문AI추천